Shanghai Kangjing Biopharmaceutical
上海康景
Shanghai Kangjing Biopharmaceutical
Biotech/Healthcare
Founded in 2017, Shanghai Kangjing is a developer and manufacturer of innovative drugs, focused on innovative drug R&D, primarily for the immunotherapy of autoimmune diseases and tumors, aiming to provide patients with comprehensive treatment services. The company has obtained clinical trial…
Latest round: Series A (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.